Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Nelson

Showing results (371-380 of 442) with videos related to

Pageof 45
Sort By:
Infection & Chemotherapy|October 6, 2016
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical TrialsJun Yong Choi, Somnuek Sungkanuparph, Thanomsak Anekthananon, et al.
Infection|October 21, 2015
Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcomeChristoph Boesecke, Patrick Ingiliz, Thomas Reiberger, et al.
Neuron|September 6, 2016
Modulating Neuronal Competition Dynamics in the Dentate Gyrus to Rejuvenate Aging Memory CircuitsKathleen M McAvoy, Kimberly N Scobie, Stefan Berger, et al.
The New England Journal of Medicine|May 30, 2003
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and AustraliaAdriano Lazzarin, Bonaventura Clotet, David Cooper, et al.
Journal of Viral Hepatitis|March 3, 2020
Transmission of hepatitis C virus in HIV-positive and PrEP-using MSM in EnglandDaniel Bradshaw, Tetyana I Vasylyeva, Chris Davis, et al.
AIDS Patient Care and Stds|March 26, 2014
Rilpivirine versus efavirenz with emtricitabine/tenofovir disoproxil fumarate in treatment-naïve HIV-1-infected patients with HIV-1 RNA ≤100,000 copies/mL: week 96 pooled ECHO/THRIVE subanalysisGeorg Behrens, Bart Rijnders, Mark Nelson, et al.
BMC Cardiovascular Disorders|January 8, 2017
Development of an Australian cardiovascular disease mortality risk score using multiple imputation and recalibration from national statisticsKathryn Backholer, Yoichiro Hirakawa, Andrew Tonkin, et al.
AIDS (London, England)|February 25, 2015
Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIVDouglas Dieterich, Mark Nelson, Vicente Soriano, et al.
Applied and Environmental Microbiology|August 12, 2018
Enhancement of Bacillus thuringiensis Cry1Ab and Cry1Fa Toxicity to Spodoptera frugiperda by Domain III Mutations Indicates There Are Two Limiting Steps in Toxicity as Defined by Receptor Binding and Protein StabilityIsabel Gómez, Josue Ocelotl, Jorge Sánchez, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2016
Efavirenz and Metabolites in Cerebrospinal Fluid: Relationship with CYP2B6 c.516G→T Genotype and Perturbed Blood-Brain Barrier Due to Tuberculous MeningitisSam Nightingale, Tran Thi Hong Chau, Martin Fisher, et al.
Pageof 45

Showing results (371-380 of 442) with videos related to

Sort By:
Pageof 45
Infection & Chemotherapy|October 6, 2016
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical TrialsJun Yong Choi, Somnuek Sungkanuparph, Thanomsak Anekthananon, et al.
Infection|October 21, 2015
Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcomeChristoph Boesecke, Patrick Ingiliz, Thomas Reiberger, et al.
Neuron|September 6, 2016
Modulating Neuronal Competition Dynamics in the Dentate Gyrus to Rejuvenate Aging Memory CircuitsKathleen M McAvoy, Kimberly N Scobie, Stefan Berger, et al.
The New England Journal of Medicine|May 30, 2003
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and AustraliaAdriano Lazzarin, Bonaventura Clotet, David Cooper, et al.
Journal of Viral Hepatitis|March 3, 2020
Transmission of hepatitis C virus in HIV-positive and PrEP-using MSM in EnglandDaniel Bradshaw, Tetyana I Vasylyeva, Chris Davis, et al.
AIDS Patient Care and Stds|March 26, 2014
Rilpivirine versus efavirenz with emtricitabine/tenofovir disoproxil fumarate in treatment-naïve HIV-1-infected patients with HIV-1 RNA ≤100,000 copies/mL: week 96 pooled ECHO/THRIVE subanalysisGeorg Behrens, Bart Rijnders, Mark Nelson, et al.
BMC Cardiovascular Disorders|January 8, 2017
Development of an Australian cardiovascular disease mortality risk score using multiple imputation and recalibration from national statisticsKathryn Backholer, Yoichiro Hirakawa, Andrew Tonkin, et al.
AIDS (London, England)|February 25, 2015
Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIVDouglas Dieterich, Mark Nelson, Vicente Soriano, et al.
Applied and Environmental Microbiology|August 12, 2018
Enhancement of Bacillus thuringiensis Cry1Ab and Cry1Fa Toxicity to Spodoptera frugiperda by Domain III Mutations Indicates There Are Two Limiting Steps in Toxicity as Defined by Receptor Binding and Protein StabilityIsabel Gómez, Josue Ocelotl, Jorge Sánchez, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2016
Efavirenz and Metabolites in Cerebrospinal Fluid: Relationship with CYP2B6 c.516G→T Genotype and Perturbed Blood-Brain Barrier Due to Tuberculous MeningitisSam Nightingale, Tran Thi Hong Chau, Martin Fisher, et al.
Pageof 45